人肝细胞微粒体

　 
        肝微粒体是体外研究一个化合物的代谢(酶抑制，清除率和代谢鉴定)以及药物-药物相互作用的主要工具。齐氏生物提供的肝细胞微粒体，每批产品都经过严格的制备、检测，确保批次间稳定性，然后于冻存管包装，10 mg/管；-80℃保存，干冰运输。

       
           微粒体产品被SCI论文引用（部分）：

1.Metabolism of chicoric acid by rat liver microsomes and bioactivity comparisons of chicoric acid and its metabolites
Q Liu, Y Wang, CX Xiao, W Wu, X Liu - Food & function, 2015 - pubs.rsc.org
… 11–14 Moreover, chicoric acid has showed anti-inflammatory, anti-bacterial, anti-HIV
activities, hypoglycemic and hepatocyte protective properties … Rat liver microsomes
were obtained from CHI Scientific, Inc. (Massachusetts, USA) 

文章链接：https://doi.org/10.1039/C5FO00073D 

2.Hypoxia-triggered gene therapy: a new drug delivery system to utilize photodynamic-induced hypoxia for synergistic cancer therapy
C Huang, J Zheng, D Ma, N Liu, C Zhu, J Li… - Journal of Materials …, 2018 - pubs.rsc.org
… Rat liver microsomes were purchased from CHI Scientific (Jiangsu China … under hypoxic conditions
(red curve); DDS in the presence of inactive rat liver microsomes and NADPH … 0 represent the
fluorescence intensity of TAMRA after and before rat liver microsome addition under …

文章链接：https://doi.org/10.1039/C8TB01805G 

   
     附：产品介绍